These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inherited factor VII deficiency: genetics and molecular pathology. Tuddenham EG; Pemberton S; Cooper DN Thromb Haemost; 1995 Jul; 74(1):313-21. PubMed ID: 8578478 [No Abstract] [Full Text] [Related]
7. Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Ruf W; Schullek JR; Stone MJ; Edgington TS Biochemistry; 1994 Feb; 33(6):1565-72. PubMed ID: 8312277 [TBL] [Abstract][Full Text] [Related]
8. A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation. Orning L; Stephens RW; Petersen LB; Hamers MJ; Stormorken H; Sakariassen KS Thromb Res; 1997 Apr; 86(1):57-67. PubMed ID: 9172287 [TBL] [Abstract][Full Text] [Related]
9. The importance of residues 195-206 of human blood clotting factor VII in the interaction of factor VII with tissue factor. Wildgoose P; Kazim AL; Kisiel W Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7290-4. PubMed ID: 2402509 [TBL] [Abstract][Full Text] [Related]
10. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit. Lingwood CA; Yiu SK Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564 [TBL] [Abstract][Full Text] [Related]
11. cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI). Enjyoji K; Emi M; Mukai T; Kato H J Biochem; 1992 May; 111(5):681-7. PubMed ID: 1639767 [TBL] [Abstract][Full Text] [Related]
12. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820 [TBL] [Abstract][Full Text] [Related]
13. The third Trp-Lys-Ser (WKS) tripeptide motif in tissue factor is associated with a function site. Rehemtulla A; Ruf W; Miles DJ; Edgington TS Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):737-40. PubMed ID: 1554354 [TBL] [Abstract][Full Text] [Related]
14. Specific molecular interaction sites on factor VII involved in factor X activation. Kumar A; Fair DS Eur J Biochem; 1993 Oct; 217(2):509-18. PubMed ID: 8223595 [TBL] [Abstract][Full Text] [Related]
15. Shared architecture of hormone binding domains in type I and II interferon receptors. Bazan JF Cell; 1990 Jun; 61(5):753-4. PubMed ID: 2140527 [No Abstract] [Full Text] [Related]
16. An Alu cassette in the cytoplasmic domain of an interferon receptor subunit. Mullersman JE; Pfeffer LM J Interferon Cytokine Res; 1995 Sep; 15(9):815-7. PubMed ID: 8536110 [TBL] [Abstract][Full Text] [Related]
17. Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factor. Ettelaie C; James NJ; Adam JM; Nicola KP; Wilbourn BR; Bruckdorfer KR Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):433-8. PubMed ID: 9657985 [TBL] [Abstract][Full Text] [Related]
19. Fibronectin receptors of phagocytes. Characterization of the Arg-Gly-Asp binding proteins of human monocytes and polymorphonuclear leukocytes. Brown EJ; Goodwin JL J Exp Med; 1988 Mar; 167(3):777-93. PubMed ID: 2965209 [TBL] [Abstract][Full Text] [Related]
20. A simple and rapid method for purifying the extracellular domain of human tissue factor. Gao B; Li S; Thorpe PE Thromb Res; 1998 Sep; 91(5):249-53. PubMed ID: 9755838 [No Abstract] [Full Text] [Related] [Next] [New Search]